<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d1 20130915//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4294342</article-id><article-id pub-id-type="pmid">25426549</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Downregulated <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Chien-Feng</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A3"><sup>3</sup></xref><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Fu-Min</given-names></name><xref ref-type="aff" rid="A5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kung</surname><given-names>Hsing-Jien</given-names></name><xref ref-type="aff" rid="A6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Li-Tzong</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref><xref ref-type="aff" rid="A7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jun-Wen</given-names></name><xref ref-type="aff" rid="A8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>Jen-Wei</given-names></name><xref ref-type="aff" rid="A9"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Shih Chen</given-names></name><xref ref-type="aff" rid="A10"><sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yu-Hui</given-names></name><xref ref-type="aff" rid="A11"><sup>11</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shau-Hsuan</given-names></name><xref ref-type="aff" rid="A12"><sup>12</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Hsuan-Ying</given-names></name><xref ref-type="aff" rid="A10"><sup>10</sup></xref></contrib></contrib-group><aff id="A1"><sup>1</sup> Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan</aff><aff id="A2"><sup>2</sup> Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan</aff><aff id="A3"><sup>3</sup> National Institute of Cancer Research National Health Research Institutes, Tainan, Taiwan</aff><aff id="A4"><sup>4</sup> Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan</aff><aff id="A5"><sup>5</sup> Departments of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan</aff><aff id="A6"><sup>6</sup> Institute of Molecular and Genomic Medicine, National Health Research Institutes, Tainan, Taiwan</aff><aff id="A7"><sup>7</sup> Department of Internal Medicine and Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan</aff><aff id="A8"><sup>8</sup> Orthopedic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan</aff><aff id="A9"><sup>9</sup> Department of Anatomic Pathology, E-Da Hospital, Kaohsiung, Tawian</aff><aff id="A10"><sup>10</sup> Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan</aff><aff id="A11"><sup>11</sup> Institute of Biosignal Transduction, National Cheng Kung University, Tainan, Taiwan</aff><aff id="A12"><sup>12</sup> Department of Internal Medicine, Division of Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Hsuan-Ying Huang, <email>a120600310@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><month>11</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>10</month><year>2014</year></pub-date><volume>5</volume><issue>22</issue><fpage>11428</fpage><lpage>11441</lpage><history><date date-type="received"><day>3</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>1</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright: © 2014 Li et al.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Myxofibrosarcomas are genetically complex and involve recurrently deleted chromosome 9p, for which we characterized the pathogenically relevant target(s) using genomic profiling. </plain></SENT>
<SENT sid="2" pm="."><plain>In 12 of the 15 samples, we detected complete or partial losses of 9p. </plain></SENT>
<SENT sid="3" pm="."><plain>The only aggressiveness-associated, differentially lost region was 9p21.3, spanning the potential inactivated methylthioadenosine phosphorylase (<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>) that exhibited homozygous (4/15) or hemizygous (3/15) deletions. </plain></SENT>
<SENT sid="4" pm="."><plain>In independent samples, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene status was assessed using quantitative- and methylation-specific PCR assays, and immunoexpression was evaluated. </plain></SENT>
<SENT sid="5" pm="."><plain>We applied <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression or knockdown to elucidate the functional roles of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> and the therapeutic potential of L-alanosine in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-preserved and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient myxofibrosarcoma cell lines and xenografts. </plain></SENT>
<SENT sid="6" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency (37%) was associated with <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene inactivation (P &lt; 0.001) by homozygous deletion or promoter methylation, and independently portended unfavorable metastasis-free survival (P = 0.0318) and disease-specific survival (P = 0.014). </plain></SENT>
<SENT sid="7" pm="."><plain>Among the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient cases, the homozygous deletion of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> predicted adverse outcome. </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient cells, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression inhibited cell migration and invasion, proliferation, and anchorage-independent colony formation and downregulated <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot>. </plain></SENT>
<SENT sid="9" pm="."><plain>This approach also attenuated the tube-forming abilities of human umbilical venous endothelial cells, attributable to the transcriptional repression of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot>, and abrogated the susceptibility to L-alanosine. </plain></SENT>
<SENT sid="10" pm="."><plain>The inhibiting effects of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression on tumor growth, angiogenesis, and the induction of apoptosis by L-alanosine were validated using <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing xenografts and reverted using RNA interference in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-preserved cells. </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, homozygous deletion primarily accounts for the adverse prognostic impact of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency and confers the biological aggressiveness and susceptibility to L-alanosine in myxofibrosarcomas. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>myxofibrosarcoma</kwd><kwd>MTAP</kwd><kwd>homozygous deletion</kwd><kwd>methylation</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="12" pm="."><plain>INTRODUCTION </plain></SENT>
</text></title><p><text><SENT sid="13" pm="."><plain>Myxofibrosarcoma is characterized by the multinodular growth of spindle to polygonal sarcoma cells within variably myxoid stroma containing long curvilinear vessels [1, 2]. </plain></SENT>
<SENT sid="14" pm="."><plain>Clinically, increased tumor grades and stages are frequently observed in myxofibrosarcomas after local recurrence, and may cause metastatic diseases [1–4]. </plain></SENT>
<SENT sid="15" pm="."><plain>However, histological evaluation is insufficiently satisfactory to predict aggressiveness of individual cases, indicating the need to elucidate the pathogenesis of myxofibrosarcoma [2, 3]. </plain></SENT>
</text></p><p><text><SENT sid="16" pm="."><plain>Genetically, complex karyotypic changes are characteristic of myxofibrosarcomas [4, 5] and a recent large-scale genomic study indicated that a nonrandom loss of chromosome 9, and particularly 9p, occurs in myxofibrosarcomas [5]. </plain></SENT>
<SENT sid="17" pm="."><plain>By using ultrahigh-resolution array comparative genomic hybridization (aCGH), we previously profiled the global copy-number alterations (CNAs) in myxofibrosarcoma specimens and cell lines and characterized <z:uniprot sup="inside" fb="0" ids="Q13309,P42843">SKP2</z:uniprot> on 5p and <z:uniprot sup="inside" fb="0" ids="Q00534">CDK6</z:uniprot> and MET on 7q as amplified oncogenes of pathogenic relevance [6–8]. </plain></SENT>
<SENT sid="18" pm="."><plain>Regarding DNA losses, chromosome 9p was the most frequently lost chromosomal arm in myxofibrosarcomas [5], prompting the search for potential tumor suppressor gene(s) underlying this selection pressure for the loss of 9p. </plain></SENT>
<SENT sid="19" pm="."><plain>We characterized methylthioadenosine phosphorylase (<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>) on 9p21.3 because whether the tumor-suppressive role of this polyamine metabolism-regulating enzyme is independent from the frequently co-deleted <z:uniprot sup="inside" fb="0" ids="Q8N726,O77618,P42771,O77617">CDKN2A</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q2KJD8,P42772">CDKN2B</z:uniprot> genes still remains debated [9–12]. </plain></SENT>
</text></p><p><text><SENT sid="20" pm="."><plain>In this study, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency in myxofibrosarcomas was associated with a poor prognosis and inactivated <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene, caused by either homozygous deletion or promoter methylation. </plain></SENT>
<SENT sid="21" pm="."><plain>Functionally, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency yielded increased aggression in myxofibrosarcoma cells. </plain></SENT>
<SENT sid="22" pm="."><plain>By restricting the adenosine monophosphate (AMP) supply [13, 14], L-alanosine induced prominent apoptosis in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient myxofibrosarcoma cells and derived xenografts. </plain></SENT>
<SENT sid="23" pm="."><plain>Collectively, the mechanistic and clinical evidence reinforces <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> as a functional tumor suppressor gene exhibiting prognostic and therapeutic relevance in myxofibrosarcomas. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec id="s2"><title><text><SENT sid="24" pm="."><plain>RESULTS </plain></SENT>
</text></title><sec id="s2_1"><title><text><SENT sid="25" pm="."><plain>Genomic profiling revealed recurrent 9p loss </plain></SENT>
</text></title><p><text><SENT sid="26" pm="."><plain>Chromosomal imbalances of varying degrees were detected in all samples subjected to aCGH profiling, indicating more recurrent deletions than gains, and exhibiting characteristically high genomic complexity. </plain></SENT>
<SENT sid="27" pm="."><plain>According to filter criteria, Nexus software revealed recurrent DNA gains in 211 chromosomal regions spanning 4577 genes in all of the genomes. </plain></SENT>
<SENT sid="28" pm="."><plain>However, 235 chromosomal regions were nonrandomly lost, involving 7871 named genes. </plain></SENT>
<SENT sid="29" pm="."><plain>In the long arm of chromosome 9, the copy number alterations were predominantly of DNA gains, except for the 9q34 region that exhibited DNA losses. </plain></SENT>
<SENT sid="30" pm="."><plain>In contrast, the complete or partial losses of 9p were detected in 12 of the 15 samples, and five major deletion cores on 9p, recurrent in ≥ 20% of samples tested, were interspersed with short stretches of DNA gains (Figures 1A, B, Supplementary Table S1). </plain></SENT>
<SENT sid="31" pm="."><plain>Within the 9p22.2-<z:uniprot sup="inside" fb="14" ids="O19002,P38936,P39689,Q07828,P50633,P50634,Q62092,Q08545,P61585,P63028,Q11118">p21</z:uniprot>.1 deletion core, the sole differentially deleted, aggressiveness-associated region on 9p was narrowed down to 9p21.3 (P = 0.0454). </plain></SENT>
<SENT sid="32" pm="."><plain>This result indicated the implication of 9p21.3 in the myxofibrosarcoma progression, in which <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> and <z:uniprot sup="inside" fb="0" ids="Q8N726,O77618,P42771,O77617">CDKN2A</z:uniprot>/<z:uniprot sup="inside" fb="0" ids="Q2KJD8,P42772">CDKN2B</z:uniprot> were homozygously deleted in 4 and 4 samples and hemizygously deleted in 3 and 3 samples, respectively (Table S2). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title><text><SENT sid="33" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> homozygous deletion in myxofibrosarcoma </plain></SENT>
</text></title><p><text><SENT sid="34" pm="."><plain>(A) Referring to chromosome 9 cytoband, genomic profiling exhibits near arm-level losses of 9p clustered in five major deletion cores (top). </plain></SENT>
<SENT sid="35" pm="."><plain>Within the middle deletion core (9p22.2-<z:uniprot sup="inside" fb="14" ids="O19002,P38936,P39689,Q07828,P50633,P50634,Q62092,Q08545,P61585,P63028,Q11118">p21</z:uniprot>.1), homozygous deletions frequently involves the aggressiveness-associated 9p21.3 region as delineated by the rectangle (middle). </plain></SENT>
<SENT sid="36" pm="."><plain>At higher magnification, the genomic locus of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene in the 9p21.3 region is illustrated (bottom). </plain></SENT>
<SENT sid="37" pm="."><plain>Frequency plots of the CNAs are expressed in blue (gain) or red (loss). (B) The close-up view of representative myxofibrosarcoma cell line (NMFH-2) and tissue (MFS96b) samples shows the homozygous deletion of the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene. </plain></SENT>
<SENT sid="38" pm="."><plain>Intratumoral nonneoplastic cells in MFS96b account for the less prominent loss of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> copies. (C) Upper: A Grade 1 myxofibrosarcoma stained with hematoxylin-eosin (left) shows diffused <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression (middle) and a preserved <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene, shown as the red curve in a quantitative DNA-PCR (right). </plain></SENT>
<SENT sid="39" pm="."><plain>Lower: A Grade 3 myxofibrosarcoma stained with hematoxylin-eosin (left) shows <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient sarcoma cells (middle) and the nondetectable <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene (right). </plain></SENT>
</text></p></caption><graphic xlink:href="oncotarget-05-11428-g001"/></fig></SecTag></sec><sec id="s2_2"><title><text><SENT sid="40" pm="."><plain>Associations of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> immunoexpression with clinicopathological and gene statuses in primary myxofibrosarcomas </plain></SENT>
</text></title><p><text><SENT sid="41" pm="."><plain>The <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> immunostain of 87 independent primary myxofibrosarcomas (Figure 1C) demonstrated an aberrant <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency in 32 cases (37%). <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene dosage was successfully determined in 79 cases, 20 of which (25.3%) exhibited homozygous deletion at an <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>/<z:uniprot sup="inside" fb="0" ids="A1A4J1,P17858,P12382,Q5R7V5,P30835">PFKL</z:uniprot> ratio of &lt; 0.2 (Table 1, Figure 1C). </plain></SENT>
<SENT sid="42" pm="."><plain>Because 13 of the 29 MTAP protein-deficient tumors were not homozygously deleted at the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene (Table 1), methylation-specific PCR was adopted to examine whether promoter hypermethylation alternatively caused protein loss, and 10 of these 13 cases were hypermethylated at the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> promoter (Table 1, Figure <z:uniprot sup="inside" fb="3" ids="P28878,P02350">S1A</z:uniprot>). </plain></SENT>
<SENT sid="43" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency was strongly related to inactivated <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> genes (P &lt; 0.001, Table 1), either by homozygous deletion or promoter methylation. </plain></SENT>
<SENT sid="44" pm="."><plain>Regarding the status of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein expression and promoter methylation, no significant difference was detected in the clincopathological features, including the tumor grading and staging. </plain></SENT>
<SENT sid="45" pm="."><plain>By contrast, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> homozygous deletion was significantly correlated with high histological grades (P = 0.006, Figure 1C, Table 1) and a high mitotic rate (P = 0.011, Figure <z:uniprot sup="inside" fb="0" ids="P47835">S1B</z:uniprot>), and marginally correlated with advanced clinical stages (P = 0.097). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title><text><SENT sid="46" pm="."><plain>Associations of clinicopathological features with <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> immunoexpression and gene status in primary myxofibrosarcomas </plain></SENT>
</text></title></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="top" colspan="3" rowspan="1"><text><SENT sid="47" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> Expression (n=87) </plain></SENT>
</text></th><th align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="48" pm="."><plain>p-value </plain></SENT>
</text></th><th align="center" valign="top" colspan="2" rowspan="1"><text><SENT sid="49" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> Gene (n=79) </plain></SENT>
</text></th><th align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="50" pm="."><plain>p-value </plain></SENT>
</text></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="51" pm="."><plain>Deficient </plain></SENT>
</text></th><th align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="52" pm="."><plain>Positive </plain></SENT>
</text></th><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="53" pm="."><plain>HD </plain></SENT>
</text></th><th align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="54" pm="."><plain>Non-HD </plain></SENT>
</text></th><th align="left" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="55" pm="."><plain>Sex </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="56" pm="."><plain>1.000 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="57" pm="."><plain>0.936 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain> Male </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>18 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>31 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>23 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain> Female </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>24 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>36 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>Age </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="69" pm="."><plain>1.000 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="70" pm="."><plain>0.854 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain> &lt;60 years </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>21 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>23 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain> ≥60 years </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>20 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>30 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>37 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>13 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>Location </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="82" pm="."><plain>0.799 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="83" pm="."><plain>0.908 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain> Extremity </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>23 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>42 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>45 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain> Axial </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>9 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>5 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>14 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>Tumor necrosis </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="95" pm="."><plain>0.483 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="96" pm="."><plain>0.115 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain> &lt;10% </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>19 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>38 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>41 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain> &gt;=10% </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>17 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>18 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>FNCLCC grade </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="4" colspan="1"><text><SENT sid="108" pm="."><plain>0.534 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="4" colspan="1"><text><SENT sid="109" pm="."><plain>0.006* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain> grade 1 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>25 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>30 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain> grade 2 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>23 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>24 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain> grade 3 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>7 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>7 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>5 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>AJCC stage </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="4" colspan="1"><text><SENT sid="126" pm="."><plain>0.763 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="4" colspan="1"><text><SENT sid="127" pm="."><plain>0.097 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain> Stage 1 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>6 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>16 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain> Stage 2 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>19 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>21 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain> Stage 3 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>20 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>20 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>10 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>Tumor size&amp; </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>7.314±6.528 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>6.347±3.701 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>0.633 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>6.600 4.808 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>7.311 5.551 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>0.612 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>Mitotic rate&amp; </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>12.81±13.143 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>10.33±1.695 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>0.585 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>8.780±9.180 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>19.050±15.408 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>0.011* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene status </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="3" colspan="1"><text><SENT sid="158" pm="."><plain>&lt;0.001 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain> Aberration (HD, PM) </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>26 (16,10) </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>4 (4,0) </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain> No aberration (no HD or PM detected) </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>3 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>46 </plain></SENT>
</text></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><text><SENT sid="165" pm="."><plain>HD: homozygous deletion, PM: promoter methylation, </plain></SENT>
</text></p><fn id="tfn-001"><label>*</label><p><text><SENT sid="166" pm="."><plain>:Statistically significant, </plain></SENT>
</text></p></fn><fn id="tfn-002"><label>&amp;</label><p><text><SENT sid="167" pm="."><plain>:t-test, </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s2_3"><title><text><SENT sid="168" pm="."><plain>Survival analyses </plain></SENT>
</text></title><p><text><SENT sid="169" pm="."><plain>Univariate correlations of the clinical outcome with various clinicopathological, immunohistochemical, and molecular parameters are shown in Table S3 and Figure 2. </plain></SENT>
<SENT sid="170" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency was a significant adverse prognosticator of an adverse DSS (P = 0.0195, Figure 2A) and was marginally predictive of a short <z:uniprot sup="inside" fb="7" ids="E5AE35">MFS</z:uniprot> (P = 0.0572, Figure 2B). </plain></SENT>
<SENT sid="171" pm="."><plain>Regarding various mechanisms regulating <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-homozygously deleted myxofibrosarcomas behaved aggressively and exhibited significantly shorter DSS (P = 0.0129, Figure 2C) and <z:uniprot sup="inside" fb="7" ids="E5AE35">MFS</z:uniprot> (P = 0.0150, Figure 2D) values than did the cases lacking homozygous deletion. </plain></SENT>
<SENT sid="172" pm="."><plain>Among the nonhomozygously deleted cases, no difference in prognosis was observed between the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-hypermethylated cases. </plain></SENT>
<SENT sid="173" pm="."><plain>Compared with the homozygously deleted cases, the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient tumors caused by methylation exhibited a trend toward more favorable outcomes (P = 0.0735, Figure 2C; P = 0.0881, Figure 2D). </plain></SENT>
<SENT sid="174" pm="."><plain>These results suggested variable implications of distinct inactivating mechanisms in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient tumors. </plain></SENT>
<SENT sid="175" pm="."><plain>In the multivariate analysis (Table S4), <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency was the single independent prognosticator of an inferior DSS (P = 0.0140, hazard ratio = 4.020) and, along with high histological grades, could predict inferior <z:uniprot sup="inside" fb="7" ids="E5AE35">MFS</z:uniprot> (P = 0.0318, hazard ratio = 2.527). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title><text><SENT sid="176" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency predicts adverse disease-specific </plain></SENT>
</text></title><p><text><SENT sid="177" pm="."><plain>(A) and metastasis-free survival (B) rates. </plain></SENT>
<SENT sid="178" pm="."><plain>Myxofibrosarcomas involving homozygously deleted <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> genes yield significantly poor outcomes for both survival endpoints (C, D) and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-methylated cases did not differ prognostically. </plain></SENT>
</text></p></caption><graphic xlink:href="oncotarget-05-11428-g002"/></fig></SecTag></sec><sec id="s2_4"><title><text><SENT sid="179" pm="."><plain>Tumor suppressive functions of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> in myxofibrosarcoma </plain></SENT>
</text></title><p><text><SENT sid="180" pm="."><plain>Because of physical proximity, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> inactivation by deletion in 9p21.3 was generally considered a bystander event concomitant with deletions of <z:uniprot sup="inside" fb="0" ids="Q8N726,O77618,P42771,O77617">CDKN2A</z:uniprot>/B [13, 14]. </plain></SENT>
<SENT sid="181" pm="."><plain>Until recently, scholars have started noticing the tumor-suppressive attributes of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> that may independently inhibit carcinogenesis [9, 11]. </plain></SENT>
<SENT sid="182" pm="."><plain>We first characterized myxofibrosarcoma cell lines regarding their <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene status and endogenous protein expression. </plain></SENT>
<SENT sid="183" pm="."><plain>Consistent with the aCGH findings, homozygous deletion in OH931 and NMFH-2 cells was confirmed using real-time PCR quantification without a detectable <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> DNA copy (Figures 3A, S2A), reflective of the absence of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein expression. </plain></SENT>
<SENT sid="184" pm="."><plain>Endogenously expressing <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>, the NMFH-1 cells were neither homozygously deleted at the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene nor methylated at its promoter (Figure 3A, <z:uniprot sup="inside" fb="3" ids="P28878,P02350">S1A</z:uniprot>). </plain></SENT>
<SENT sid="185" pm="."><plain>Therefore, we applied <z:uniprot sup="inside" fb="0" ids="Q9UMX9,Q4LE88">MATP</z:uniprot>-bearing vectors and shMTAP to decipher how inactivated <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> modulates myxofibrosarcoma phenotypes regarding various cancer hallmarks. </plain></SENT>
<SENT sid="186" pm="."><plain>The stably transfected and knockdown clones were validated using western blots (Figure 3B). </plain></SENT>
<SENT sid="187" pm="."><plain>In the NMFH-1 cells, the silencing of the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> transcript with 2 stable clones of shMTAP was determined using real-time quantitation (Figure S2B). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title><text><SENT sid="188" pm="."><plain>In vitro growth-inhibiting function of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> linked to downregulated <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot> </plain></SENT>
</text></title><p><text><SENT sid="189" pm="."><plain>(A) Compared with reference CCD966SK fibroblasts, the OH931 and NMFH-2 cell lines were homozygously deleted at the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene; no DNA copy was detected using real-time PCR (left) and the western blots exhibited no <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression (right). </plain></SENT>
<SENT sid="190" pm="."><plain>Although the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene dosage was slightly decreased, a western blotting assay revealed <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing NMFH-1 cells. (B) Stable exogenous <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression was achieved in the OH931 (left) and NMFH-2 (middle) myxofibrosarcoma cell lines, and the western blots exhibited the expected bands using anti-<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>. </plain></SENT>
<SENT sid="191" pm="."><plain>Two clones of shMTAP stably downregulated <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression in NMFH-1 cells exhibiting decreased protein abundance (right), compared with the non-targeting shLacZ controls. (C) The BrdU readout, indicating the level of proliferative activity, was significantly reduced in stable <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-transfected NMFH-2 cells (left), but increased in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-silenced NMFH-1 cells (right), compared with the corresponding controls. </plain></SENT>
<SENT sid="192" pm="."><plain>Depending on the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression status, only the expression level of <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot> in western blots was consistently altered as expected among the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 cells and 2 MTAP-knockdown clones of the NMFH-1 cells. (D) Compared with the empty controls (left), the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 transfectants (middle) formed fewer colonies on soft agar, as expressed in the histogram (bottom). </plain></SENT>
</text></p></caption><graphic xlink:href="oncotarget-05-11428-g003"/></fig></SecTag></sec><sec id="s2_5"><title><text><SENT sid="193" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression inhibited cell proliferation and colony formation of myxofibrosarcoma primarily through the downregulation of <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot> </plain></SENT>
</text></title><p><text><SENT sid="194" pm="."><plain>To elucidate the potential <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-associated antitumor function, we compared the BrdU readout of myxofibrosarcoma cells engineered to manifest various <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression levels. </plain></SENT>
<SENT sid="195" pm="."><plain>In the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 myxofibrosarcoma transfectants, the readout indicative of cell proliferation significantly reduced, whereas shMTAP effectively promoted cell proliferation in the NMFH-1 cells exhibiting endogenous <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> (Figure 3C). </plain></SENT>
<SENT sid="196" pm="."><plain>By using an ECIS assay, we measured NMFH-2 cells for real-time cell proliferation, revealing a significantly slow cell growth rate in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing transfectants (Figure S2C). </plain></SENT>
<SENT sid="197" pm="."><plain>These observations supported that <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> may dampen the proliferation of myxofibrosarcoma, prompting investigating whether <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression modulates cell cycle regulators and inhibits colony formation. </plain></SENT>
<SENT sid="198" pm="."><plain>We performed western blotting to evaluate alterations in the G1- and G1/S-associated <z:uniprot sup="inside" fb="1" ids="Q00268,Q00265,O01377,P24314,P17917,P12004,P17918,P17070,P61074,P31008,P04961,O16852,P22177,P53358,P18248">cyclins</z:uniprot> and <z:uniprot sup="inside" fb="1" ids="Q00268,Q00265,O01377,P24314,P17917,P12004,P17918,P17070,P61074,P31008,P04961,O16852,P22177,P53358,P18248">cyclin</z:uniprot>-dependent kinases. </plain></SENT>
<SENT sid="199" pm="."><plain>Among these, only <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot> expression was consistently downregulated in both <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 cells and shLac-transfected NMFH-1 cells (Figure 3C). </plain></SENT>
<SENT sid="200" pm="."><plain>However, the trend in alterations in <z:uniprot sup="inside" fb="1" ids="Q00268,Q00265,O01377,P24314,P17917,P12004,P17918,P17070,P61074,P31008,P04961,O16852,P22177,P53358,P18248">cyclin</z:uniprot> E and <z:uniprot sup="inside" fb="0" ids="Q5E9Y0,O55076,P24941,P48963">CDK2</z:uniprot> expression varied between exogenous expression and RNA interference approaches as well as between 2 shMTAP clones. </plain></SENT>
<SENT sid="201" pm="."><plain>In the flow cytometric analysis, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 cells exhibited significant cell cycle arrest in the G1 phase and concomitant low percentages of cells in the S and G2 phases (Figure S2D). </plain></SENT>
<SENT sid="202" pm="."><plain>In a soft-agar assay, significantly small and few cell colonies were observed in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 transfectants, substantiating the inhibition of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> in anchorage-independent growth (Figure 3D). </plain></SENT>
<SENT sid="203" pm="."><plain>These findings imply that <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot> represents the predominant cell cycle regulator associated with the antiproliferative role of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>. </plain></SENT>
</text></p></sec><sec id="s2_6"><title><text><SENT sid="204" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression inhibited cell migration and invasion </plain></SENT>
</text></title><p><text><SENT sid="205" pm="."><plain>The results of wound-healing assays indicated significantly rapid wound closure in both NMFH-2 cells transfected with an empty vector and NMFH-1 cells silenced against endogenous <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> (Figure <z:uniprot sup="inside" fb="3" ids="P09353">S3A</z:uniprot>,C). </plain></SENT>
<SENT sid="206" pm="."><plain>According to matrigel invasion assays, the 2 conditions also yielded significantly increased invading tumor cells (Figure <z:uniprot sup="inside" fb="0" ids="P42307">S3B</z:uniprot>), indicating enhanced metastatic propensity by <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency in myxofibrosarcomas. </plain></SENT>
</text></p></sec><sec id="s2_7"><title><text><SENT sid="207" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression conferred antiangiogenic function </plain></SENT>
</text></title><p><text><SENT sid="208" pm="."><plain>Recently, we reported that aberrant loss of argininosuccinate synthetase (<z:uniprot sup="inside" fb="0" ids="P14568,Q5ZJ23,P00966">ASS1</z:uniprot>) caused by promoter methylation may contribute to the enhanced angiogenesis in myxofibrosarcomas [15]. </plain></SENT>
<SENT sid="209" pm="."><plain>Because <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> is linked to polyamine metabolism and adenine and methionine salvage [16, 17], examining whether <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> inactivation promotes angiogenesis by perturbing the metabolic balance of sarcoma cells is conceivable, similar to the scenario involved in deregulated <z:uniprot sup="inside" fb="0" ids="P14568,Q5ZJ23,P00966">ASS1</z:uniprot>. </plain></SENT>
<SENT sid="210" pm="."><plain>Under various experimental conditions used to manipulate <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression, 3 myxofibrosarcoma cell lines were assessed for the formation of HUVEC tubes incubated with corresponding conditioned media. </plain></SENT>
<SENT sid="211" pm="."><plain>Using HUVEC assays, the angiogenic capability significantly decreased to 55% and 60% in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing OH931 and NMFH-2 transfectants, respectively, but significantly increased up to 2~3-fold in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-silenced NMFH-1 cells (Figure 4A). </plain></SENT>
<SENT sid="212" pm="."><plain>Because of increased angiogenesis in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient state, we used an RT-PCR expression array to explore the potential mediators relevant to <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-regulated angiogenesis. </plain></SENT>
<SENT sid="213" pm="."><plain>Lacking upregulated genes in this angiogenesis-associated panel, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 cells showed significantly reduced mRNA expression of 6 candidates (Table S5). </plain></SENT>
<SENT sid="214" pm="."><plain>Of these, CXCL-9, CXCL-10, and <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> proteins were concomitantly downregulated using western blots in both NMFH-2 and OH931 <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing cell lines, the conditioned media of which also consistently demonstrated decreased <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> protein concentration using ELISA (Figure 4B). </plain></SENT>
<SENT sid="215" pm="."><plain>Real-time RT-PCR showed decreased expression of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> mRNA in both <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing myxofibrosarcoma cell lines (Figure 4C). </plain></SENT>
<SENT sid="216" pm="."><plain>In the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-silenced NMFH-1 cells used for cross-validation, <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> was the only molecule that exhibited upregulated mRNA and protein expression (Figure 4B, C). </plain></SENT>
<SENT sid="217" pm="."><plain>The <z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">luciferase</z:uniprot> activity of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> promoter significantly reduced in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing OH931 and NMFH-2 cells (Figure 4D). </plain></SENT>
<SENT sid="218" pm="."><plain>These data demonstrated that <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency enhanced the transcriptional upregulation of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> to promote angiogenesis in myxofibrosarcomas. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title><text><SENT sid="219" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> governs tumor angiogenesis by the transcriptional repression of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> </plain></SENT>
</text></title><p><text><SENT sid="220" pm="."><plain>(A) The well-formed HUVEC tubes decrease when exposed to conditioned media from <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing transfectants of NMFH-2 and OH931 cells. </plain></SENT>
<SENT sid="221" pm="."><plain>Conversely, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> knockdown promoted angiogenesis in both shMTAP-transduced clones of the NMFH-1 cells (left). </plain></SENT>
<SENT sid="222" pm="."><plain>The relative level of angiogenic tube-forming activity is expressed in the histograms (right). (B) Of the differentially expressed genes identified from the RT-PCR expression array, western blotting validation for both <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing transfectants exhibited correspondingly decreased protein expression of CXCL-9, CXCL-10, and <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> (left). </plain></SENT>
<SENT sid="223" pm="."><plain>The <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> protein concentration secreted into the conditioned media was significantly reduced in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 and OH931 cell lines (middle). </plain></SENT>
<SENT sid="224" pm="."><plain>Only the level of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> protein expression was significantly upregulated in the cross-validation of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-silenced NMFH-1 cells (right). (C) As a representative potential downstream mediator of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>, the <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> mRNA expression levels were significantly downregulated in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 and OH931 cells (left) but elevated by <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> knockdown using quantitative RT-PCR (right). (D) <z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">Luciferase</z:uniprot> activity of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> promoter construct was significantly lower in the NMFH-2 and OH931 cells transfected with the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing vector than in the empty controls. </plain></SENT>
<SENT sid="225" pm="."><plain>All experiments were performed in triplicate, and the results are expressed as mean ± SD. </plain></SENT>
</text></p></caption><graphic xlink:href="oncotarget-05-11428-g004"/></fig></SecTag></sec><sec id="s2_8"><title><text><SENT sid="226" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression inhibited growth of xenografted tumors </plain></SENT>
</text></title><p><text><SENT sid="227" pm="."><plain>The in vivo inhibitory effect of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> on tumor growth was analyzed in NMFH-2 xenografts exhibiting ectopic <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression versus empty controls (Figure 5A). </plain></SENT>
<SENT sid="228" pm="."><plain>The xenografts reexpressing <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> exhibited a significantly small average tumor volume from Day 7 until sacrifice on Day 30, on which the excised specimens were evidently larger and heavier in the controls than were those in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing group. </plain></SENT>
<SENT sid="229" pm="."><plain>The control xenografts exhibited more high-grade pleomorphic cells in a fibromyxoid matrix and a higher mitotic rate (P &lt; 0.001) compared with the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing xenografts primarily composed of low-grade spindle cells. </plain></SENT>
<SENT sid="230" pm="."><plain>Immunohistochemically, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing xenografts exhibited a significantly reduced labeling of <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot>, <z:uniprot sup="inside" fb="1" ids="Q00268,Q00265,O01377,P24314,P17917,P12004,P17918,P17070,P61074,P31008,P04961,O16852,P22177,P53358,P18248">cyclin</z:uniprot> E, and Ki-67, as well as decreased intratumoral vessels stained with the CD31 endothelial marker, substantiating the antiproliferative and antiangiogenic attributes of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> in vivo. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title><text><SENT sid="231" pm="."><plain>In vivo tumor suppressive function of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> and the inhibition of L-alanosine in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient myxofibrosarcoma </plain></SENT>
</text></title><p><text><SENT sid="232" pm="."><plain>(A) The average tumor volume of the empty vector-transfected NMFH-2 xenografts was significantly larger than that of the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing counterparts (left). </plain></SENT>
<SENT sid="233" pm="."><plain>On Day 30, the excised xenografts were grossly larger and heavier in the control group than in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing group (middle). </plain></SENT>
<SENT sid="234" pm="."><plain>Histologically, control xenografts (upper panel) comprise <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient high-grade pleomorphic sarcoma cells that exhibit frequent mitotic figures, the increased expression of <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot>, <z:uniprot sup="inside" fb="1" ids="Q00268,Q00265,O01377,P24314,P17917,P12004,P17918,P17070,P61074,P31008,P04961,O16852,P22177,P53358,P18248">cyclin</z:uniprot> E, Ki-67, and <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot>, and an increased microvascular density based on CD31 staining. </plain></SENT>
<SENT sid="235" pm="."><plain>However, contrasting results were observed in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing group (lower panel), which exhibited low-grade <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing spindle cells (right). (B) L-alanosine effectively attenuated the viability of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient NMFH-2 and OH931 myxofibrosarcoma cell lines, and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing NMFH-1 cells were relatively resistant to L-alanosine, demonstrating &gt;50% viable sarcoma cells, even at 100 μM (left). </plain></SENT>
<SENT sid="236" pm="."><plain>Unlike the sensitivity in the parent lines and empty controls, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression caused decreased susceptibility to L-alanosine in the OH931 (middle) and NMFH-2 (right) cells. (C) The average tumor volume was significantly larger in the PBS-treated group than in the groups treated with 25 μM and 50 μM of L-alanosine (left). </plain></SENT>
<SENT sid="237" pm="."><plain>On Day 42, the excised xenografts remained macroscopically larger and heavier in the control group, exhibiting no dose-dependent difference between the groups treated with 25 μM and 50 μM of L-alanosine (middle). </plain></SENT>
<SENT sid="238" pm="."><plain>In contrast to the high-grade pleomorphic histology in the control xenografts lacking apparent apoptosis, the L-alanosine-treated group exhibited increased numbers of fibrohyaline collagen fibers and TUNEL-labeled apoptotic cells (right). </plain></SENT>
</text></p></caption><graphic xlink:href="oncotarget-05-11428-g005"/></fig></SecTag></sec><sec id="s2_9"><title><text><SENT sid="239" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency was associated with increases of proliferative index, microvessel density, and <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> expression level in primary myxofibrosarcomas </plain></SENT>
</text></title><p><text><SENT sid="240" pm="."><plain>In a subset common cohort of 40 primary myxofibrosarcomas yielding informative scoring results (Table S6, Figure S4), we further corroborated the in vitro findings in clinical samples that <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> protein deficiency was highly associated with increased Ki-67 labeling index (p &lt; 0.001), microvessel density (p = 0.002) assessed by CD31 staining [18], and <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> expression levels (p &lt; 0.001) evaluated by H-score method [19]. </plain></SENT>
</text></p></sec><sec id="s2_10"><title><text><SENT sid="241" pm="."><plain>L-alanosine inhibited <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient myxofibrosarcoma cells and xenografts by inducing apoptosis </plain></SENT>
</text></title><p><text><SENT sid="242" pm="."><plain>Because L-alanosine can completely abrogate AMP supply in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient cells, we investigated whether L-alanosine can effectively inhibit this aggressive subset of myxofibrosarcomas by targeting the methionine de novo pathway [13]. </plain></SENT>
<SENT sid="243" pm="."><plain>All myxofibrosarcoma cell lines were incubated with indicated doses of L-alanosine for 72 h; this attenuated the cell viability in only the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient parent NMFH-2 and OH931 cells yielding IC50 values of approximately 1 μM and 5 μM, respectively, but not in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing NMFH-1 cells (Figure 5B). </plain></SENT>
<SENT sid="244" pm="."><plain>Flow cytometry demonstrated a significantly increased sub-G1 population in both L-alanosine-treated OH931 and NMFH-2 cells, and the induction of apoptosis, particularly prominent in the NMFH-2 cells, was validated using <z:uniprot sup="inside" fb="0" ids="P81287,P17153,P70075,P08758,Q4R4H7,P48036,Q5R1W0,P14668">annexin V</z:uniprot>/propidium iodide staining assays (Figure S5). </plain></SENT>
<SENT sid="245" pm="."><plain>Stable <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing OH931 and NMFH-2 cells were employed to explore how <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression affected the susceptibility of myxofibrosarcoma cells to L-alanosine (Figure 5B). </plain></SENT>
<SENT sid="246" pm="."><plain>This approach significantly reverted the attenuated cell viability caused by L-alanosine, indicating that its antitumor selectivity was attributable to the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency in myxofibrosarcoma cells. </plain></SENT>
</text></p><p><text><SENT sid="247" pm="."><plain>We evaluated the in vivo efficacy of L-alanosine in NMFH-2 xenografts (Figure 5C). </plain></SENT>
<SENT sid="248" pm="."><plain>From Day 25 posttreatment until Day 42 at sacrifice, significantly smaller tumor volumes were observed in both groups treated with L-alanosine at 25 μM or 50 μM, compared with the PBS controls. </plain></SENT>
<SENT sid="249" pm="."><plain>However, no dose-dependent therapeutic effect was observed. </plain></SENT>
<SENT sid="250" pm="."><plain>The control xenografts exhibited high-grade pleomorphic histology characterized by frequent atypical mitoses, whereas the L-alanosine-treated specimens exhibited quiescent or apoptotic-appearing cells in a fibromyxoid backdrop containing increased hyaline collagenous fibers. </plain></SENT>
<SENT sid="251" pm="."><plain>In the L-alanosine-treated xenografts, significantly increased TUNEL-labeled apoptotic cells were observed (P &lt; 0.001), substantiating the in vivo apoptosis-inducing effect of L-alanosine. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="s3"><title><text><SENT sid="252" pm="."><plain>DISCUSSION </plain></SENT>
</text></title><p><text><SENT sid="253" pm="."><plain>Myxofibrosarcoma is a common, and genetically complex sarcoma of histological and biological heterogeneity, and its therapeutic mainstay is conducting radical surgery to achieve clear margins [2, 3]. </plain></SENT>
<SENT sid="254" pm="."><plain>The lack of effective molecular markers and standardized chemoradiotherapeutic regimen(s) dictates an unfavorable prognosis in primary advanced and recurrent myxofibrosarcomas [2, 3]. </plain></SENT>
<SENT sid="255" pm="."><plain>By integrating various methodologies, we identified the clinical, biological, and therapeutic relevance of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency, which was observed in 37% of primary myxofibrosarcomas, strongly linked to homozygous deletion or promoter methylation, and independently predictive of adverse survival. </plain></SENT>
<SENT sid="256" pm="."><plain>However, no inactivating mechanism was detected in the 3 MTAP-deficient cases, suggesting that <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> downregulation was caused by alternative molecular defects such as small deletions of 5′ regions [20, 21]. </plain></SENT>
<SENT sid="257" pm="."><plain>On the other hand, homozygous deletion of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene was detected in four cases interpreted as <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing. </plain></SENT>
<SENT sid="258" pm="."><plain>This conflicting finding was most likely attributable to the existence of intratumoral heterogeneity. </plain></SENT>
<SENT sid="259" pm="."><plain>Whatever whole-block or tissue microarray sections, the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-positive tumor cells only ranged from 10% to 20% at most, which might not be isolated in the process of laser capture microdissection and therefore result in an underestimated gene ratio skewed toward homozygous deletion. </plain></SENT>
<SENT sid="260" pm="."><plain>Compared with the equally indolent <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-hypermethylated and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing myxofibrosarcomas, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-homozygously deleted tumors were often high-grade and clinically aggressive. </plain></SENT>
<SENT sid="261" pm="."><plain>This variation in the prognostic effect of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene abrogation between distinct mechanisms in myxofibrosarcoma progression was concordant with our previous findings regarding GISTs [22], indicating the probable random occurrence of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> promoter methylation in the early phase of myxofibrosarcoma tumorigenesis. </plain></SENT>
<SENT sid="262" pm="."><plain>However, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> homozygous deletion represents a relatively late genetic event in the tumor progression, which may confer survival advantage to aggressive subclones of myxofibrosarcoma cells and thereby culminate in negative prognostic impact. </plain></SENT>
</text></p><p><text><SENT sid="263" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> depletion is not uncommon in human malignancies and is primarily attributable to homozygous deletions spanning 9p21.3. </plain></SENT>
<SENT sid="264" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency may occur without the loss of adjoining <z:uniprot sup="inside" fb="0" ids="Q8N726,O77618,P42771,O77617">CDKN2A</z:uniprot> in non-small cell lung cancers and gliomas [13, 14, 23–26]. </plain></SENT>
<SENT sid="265" pm="."><plain>Instead of genomic losses, promoter hypermethylation represents the preponderant inactivating mechanism in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient hepatocellular carcinomas [21]. </plain></SENT>
<SENT sid="266" pm="."><plain>Functionally, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deleted breast cancer cells may inhibit anchorage-independent growth and in vivo tumorigenicity [9]. </plain></SENT>
<SENT sid="267" pm="."><plain>Although mice heterozygous for germline <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> mutations did not fully recapitulate the genetic events in clinical specimens, they were prone to developing T-cell lymphomas; however, homozygous inactivation was embryonically lethal in the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-knockout murine model [11]. </plain></SENT>
<SENT sid="268" pm="."><plain>Because of these conflicting findings, whether the loss of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> activity is pathogenically relevant remains debated [9, 11, 12]. </plain></SENT>
<SENT sid="269" pm="."><plain>Given the clinical relevance of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency in myxofibrosarcomas, we characterized the biology of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression to clarify its functional effects on cancer hallmark-related phenotypes. </plain></SENT>
<SENT sid="270" pm="."><plain>The antiproliferative function of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> by the downregulation of <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot> was validated using both <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> knockdown in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing NMFH-1 cells and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpression in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient NMFH-2 cells. </plain></SENT>
<SENT sid="271" pm="."><plain>Regarding the latter condition, the growth-inhibiting attribute of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> was reinforced by the reduced proliferation evidenced in the ECIS measurements, few colonies in the soft-agar assays, and low-grade histology of the corresponding xenografted specimens exhibiting an underexpression of Ki-67 and <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot>. </plain></SENT>
<SENT sid="272" pm="."><plain>We also corroborated the suppressive role of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> in metastasis, which is the leading cause of sarcoma-associated mortality and critically involves the regulation of cell motility and transgression through an extracellular matrix [2, 27, 28]. </plain></SENT>
<SENT sid="273" pm="."><plain>In <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing NMFH-2 cells, delayed closure in wound-healing assays and decreased invading cells through matrix-coated wells were measured and cross-validated by the reverse results of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-silenced NMFH-1 cells. </plain></SENT>
<SENT sid="274" pm="."><plain>Clinically, the independent effect of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency on adverse <z:uniprot sup="inside" fb="7" ids="E5AE35">MFS</z:uniprot> in myxofibrosarcomas was reflective of these <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-associated antimigratory and antiinvasive functions. </plain></SENT>
</text></p><p><text><SENT sid="275" pm="."><plain>In <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing and shLacZ-transduced myxofibrosarcoma cells, angiogenic capability was significantly impaired, as indicated by reduced levels of HUVEC-derived tube formation. </plain></SENT>
<SENT sid="276" pm="."><plain>Collectively, these findings corroborated endogenous <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> as a functional suppressor that governs myxofibrosarcoma pathogenesis by inhibiting tumor proliferation, metastasis, and angiogenesis. </plain></SENT>
<SENT sid="277" pm="."><plain>In the <z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">luciferase</z:uniprot> reporter assay, the antiangiogenic effect of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> was determined to primarily link to the transcriptional repression of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot>, ultimately attenuating mRNA and protein expression in the myxofibrosarcoma cells. </plain></SENT>
<SENT sid="278" pm="."><plain>In the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient xenografts and myxofibrosarcoma specimens, <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> overexpression was present in the tumor cells and extracellular stroma and associated with increased microvessel density. </plain></SENT>
<SENT sid="279" pm="."><plain>These exemplified the oncogenic role of <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> in myxofibrosarcoma pathogenesis and corresponded with previous reports on its associations with aggressiveness in various cancer types [15, 28]. </plain></SENT>
<SENT sid="280" pm="."><plain>Kiroviski reported that <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> knockdown upregulated <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> expression through the accumulation of 5′-deoxy-5′-methylthioadenosine in hepatocellular carcinomas [29]. </plain></SENT>
<SENT sid="281" pm="."><plain>However, they neither elucidated the mechanistic link between <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency and <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> nor characterized the functional effect of this perturbed regulatory chain on angiogenesis and metastasis. </plain></SENT>
</text></p><p><text><SENT sid="282" pm="."><plain>Because <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> is not a transcriptional factor, it is conceivable to hypothesize that <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency indirectly transactivates an <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> promoter, causing resultant aggressive phenotypes. </plain></SENT>
<SENT sid="283" pm="."><plain>Recently, we reported that the antiangiogenic function of <z:uniprot sup="inside" fb="0" ids="P14568,Q5ZJ23,P00966">ASS1</z:uniprot>, a rate-limiting enzyme converting citrulline into arginine in the urea cycle, was also attributable to the inhibition of <z:uniprot sup="inside" fb="0" ids="P14568,Q5ZJ23,P00966">ASS1</z:uniprot> on <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> expression in myxofibrosarcomas [15]. </plain></SENT>
<SENT sid="284" pm="."><plain>Evidently, aberrant losses of both <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> in methionine salvage and <z:uniprot sup="inside" fb="0" ids="P14568,Q5ZJ23,P00966">ASS1</z:uniprot> in arginine metabolism may upregulate <z:uniprot sup="inside" fb="0" ids="P27117,P41931,P78599,Q8S3N2,P27118,P14019,P50134,P44317,P11926,P27116,P00860,P27119,P27121,P49725,Q92445,P09057,Q9UQW9,O22616,P07805,P08432">ornithine decarboxylase</z:uniprot> (<z:uniprot sup="inside" fb="3" ids="P40807,P40808,P27117,P41931,P78599,Q8S3N2,P27118,P14019,P50134,Q54UF3,P11926,P43099,P27116,P00860,P27119,P27121,P49725,Q92445,P09057,Q9UQW9,O22616,P07805,P08432,A0JN87,Q9BQT8,Q5RFB7">ODC</z:uniprot>) and subsequently induce overproduction of putrescine and other polyamines [17, 30, 31]. </plain></SENT>
<SENT sid="285" pm="."><plain>This alteration is one of the first processes involved in proliferating cells preceding nucleic acid and protein syntheses and recently has been reported to promote tumor development and progression involving multiple cancer hallmarks [16, 30]. </plain></SENT>
<SENT sid="286" pm="."><plain>For instance, <z:uniprot sup="inside" fb="3" ids="P40807,P40808,P27117,P41931,P78599,Q8S3N2,P27118,P14019,P50134,Q54UF3,P11926,P43099,P27116,P00860,P27119,P27121,P49725,Q92445,P09057,Q9UQW9,O22616,P07805,P08432,A0JN87,Q9BQT8,Q5RFB7">ODC</z:uniprot> transformants were reported to increase secreted <z:uniprot sup="inside" fb="0" ids="Q9GLE5,Q90611,P08253,P33434,P50757,P33436">MMP-2</z:uniprot> in vitro to enhance matrix degradation [30]. </plain></SENT>
<SENT sid="287" pm="."><plain>Analogously, <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> overexpression in the <z:uniprot sup="inside" fb="0" ids="P14568,Q5ZJ23,P00966">ASS1</z:uniprot>-deficient and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient myxofibrosarcomas is likely mediated by overexpressed <z:uniprot sup="inside" fb="3" ids="P40807,P40808,P27117,P41931,P78599,Q8S3N2,P27118,P14019,P50134,Q54UF3,P11926,P43099,P27116,P00860,P27119,P27121,P49725,Q92445,P09057,Q9UQW9,O22616,P07805,P08432,A0JN87,Q9BQT8,Q5RFB7">ODC</z:uniprot>, which converges growth-promoting signals to orchestrate transcriptional regulation. </plain></SENT>
</text></p><p><text><SENT sid="288" pm="."><plain>The disabled methionine salvage in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-inactivated myxofibrosarcomas renders this aggressive tumor subset a tumor-specific metabolic feature for use in L-alanosine therapy, which targets <z:uniprot sup="inside" fb="0" ids="B0CBU2,A1TM37,Q6FCS7,A0LWT8,A5G293,B9MFY7,P52151,A1W588,A3N181,B3H1V8,B0BQ12,A6VQD4,Q17G75,P96771,Q8UCN6,B9J8Q9,B9JRD7,C0NL18,C6HBB1,A6R8V2,C5GA45,Q0VMF3,Q5E2D3,Q0AB55,A6TXB3,B4S195,B8JDH9,Q2IQF7,A7HDA9,Q5PAA8,B4UGW9,O67321,A8ER43,O29417,Q5P7C4,C5FC83,A0JSA1,Q75E56,A1CNR3,B0XNF8,B8MZA3,Q4WRQ7,A2QB52,Q2UQQ2,Q0CM45,A8I1V7,B6YR45,A1K400,C1DLQ8,A7AU38,A0RLP6,Q81JI9,Q72WW1,A7GVN0,Q814H1,Q630D5,Q5LAD5,Q64QR7,Q9K5R0,Q6HAG9,Q65CR5,A8FJC0,Q5WAI0,P29726,Q8A6N4,A6L1X1,A7ZAP4,A1URK5,Q6G4G5,Q6G1A4,A9IQ57,Q1LSQ9,Q6MN06,B2ICM9,C5C333,B8DVC2,A0ZZG5,B3DNT3,Q8G6T9,B7GT29,C5JKJ6,Q7VQP1,Q494F3,Q2KYA7,Q7WHP1,B5RLY1,Q7W6Q7,A9IK82,Q7VWM1,B5RRM9,A1QZK9,Q89EM1,C0R2E2,A5ED09,A4Z0B8,C0ZA40,Q2YQI5,P0C115,A9M7I3,A8QE42,C0REU7,P65878,A5VS40,A9WWG0,P65879,B8D8D0,P57629,Q8K916,B8D887,P59428,A3MK63,A2S2B3,Q62JX6,A1V4I9,A3NVV9,Q3JRR4,A3NA42,Q63US2,Q2SWD3,A8X7H5,P91134,B9MLK0,Q8R6T8,A4XML6,A7ZFJ4,A7H0A8,A0RMY9,A7I328,A8FNG4,A7H5L7,Q9PMG4,A1W1A5,Q5HST3,B9KF91,P0CH96,P0CH97,B9W8Y2,Q6FMU9,C5MBF2,Q3A8S5,B0T890,Q9A3U9,B8H3C9,Q2H9E8,Q11DJ4,Q3APK8,B3EGV7,B3QQZ0,A1BJ01,A4SCU2,Q8KAK6,Q1QY21,A8AMM3,Q97D87,A7FZF9,C3KWG8,A6M3K0,B2V1S6,B2TRE4,A5I7Y9,C1FNL8,B1IHP2,A7GJL2,B1KU85,Q181Q7,A5N4D3,A0PXA8,Q8XH63,C5PAD0,Q48A17,A8NDT2,C3PJK0,Q9RHX5,Q6NF38,Q8FMB0,A4QHG2,Q8NM16,Q4JXT3,B1VHT9,B6J734,B6J083,A9KCC7,A9NCS8,Q83CV4,B1WSJ0,A7MM94,P0CQ35,P0CQ34,B0W9B4,Q1LLK1,Q6A6A3,B8HY86,Q11UE6,Q6BUG5,Q47BS7,Q3Z7V0,A5FQS4,Q3ZXV0,C1CZ40,Q1J1X6,Q9RYB5,A9BMU3,C6BRT2,Q317B9,C0QB49,B8FB83,B1I6P8,B8J4N1,B8G0I5,Q24MC6,A8ZTF0,Q6AN65,A4J9P7,Q725K9,B8DQ18,A1V9U1,P21900,A5EVE1,A8LIN4,B3M343,B3P321,B4JUE4,Q9Y0Y2,B4K8W7,B4G518,Q299D3,B4II68,B4LWK0,B4NFS5,B4PPT4,A7ZV47,B7UQI6,B7MKY1,B7LC36,P0A7D6,B5Z2I3,B7NTN3,B7MSJ5,B7M8T7,C4ZR54,B1XDS8,A8A7S2,A1AJ82,Q0T9L6,P0A7D5,B1IT29,P0A7D4,B7NGB1,B6I281,B1LQJ7,Q1R383,O31047,Q3YRQ6,Q2GH05,Q5FFQ3,Q5HAW8,Q5BEY7,A4W5R8,Q839Y4,B2VCW8,Q2NCV0,B7LLV9,B1YG93,C4L014,A7HMJ8,B0RZL3,A5FHR3,A6H0U4,Q0RBA3,Q2J4S8,B0TVV8,A8LDR3,Q14JN1,A7NEW1,Q2A167,B2SE78,A0Q4C3,Q0BJY9,Q5NI78,A4J037,P58793,O68581,B5ECF3,B9M1R2,Q5KU76,B3EAS4,Q39QK1,Q747F9,C6DZQ7,C5D9W9,A4ITU9,A5GC19,B7KCX9,Q7NG93,A9HLQ1,Q5FQZ9,Q0BTV7,A0LZF7,Q7VKR5,Q4QL68,A5UCM6,A5UIZ2,P45283,B8F8E6,Q0I4Q5,Q2SBC8,A1WUT0,Q5V2N1,B8D1A3,B0R4U8,Q9HQM6,C4K3C2,Q17W85,Q7VHL2,B0TA52,B6JKI4,B5ZA21,Q1CUP8,Q9ZMI1,B2US87,P56137,A4G4L2,B0UW92,A3DK09,Q31GN4,B4U9K9,Q0BXJ3,Q5QW95,Q28MG6,A6WFJ3,B5Y325,A6TH93,Q6CQ65,B2GL12,C4R8E8,Q1IJT2,Q5FHY4,Q03TS9,B3W7G1,Q1GBV4,B2GEZ1,Q045S7,A8YTK4,Q74KY3,Q9CE93,A2RN80,Q02WK8,Q03CT6,Q88SV6,A5VHM0,B2G550,Q1WRH2,Q38ZL5,C5DD42,Q1MRW8,Q5X7Q5,A5IHA9,Q5ZY86,Q5WZ56,Q8RNM2,A4H7A3,A7LBL2,A4HVP7,Q4QG35,Q6ACB0,Q72PA7,Q8F738,B1N002,Q03W69,Q92FQ5,C1KV62,Q725A8,B8DAL0,Q8YAR1,A0AEN2,A5DSZ3,B1HPK4,A0L7T9,A4QXV8,Q2W2D1,A8Q0E3,Q65S32,A1U4C0,Q0AS86,A6VYL0,Q6F243,A6UT04,Q46FF6,Q12ZI9,B7L289,Q606N8,Q1H0Y6,Q57981,A4FW92,A9A9N1,A6VH18,Q8PYQ9,Q6LXC0,B8IPM5,B1Z962,A2SHA4,B1M1K0,A5UN95,B0UJ78,B8EK29,Q2NFM9,O26712,A0B8Q8,A6UQ77,B0JXF6,C5C8H9,A9UTP3,Q2RG43,A0QLW6,B1MIV1,P65881,A1KFH8,C1AK32,Q2SR96,A4T142,B8ZU80,O69595,B2HPW4,Q6MSC7,Q73T50,Q8EVI1,A0QQH7,A3PTT9,A1UA84,Q1BEP8,A5TZ84,P9WHN2,P9WHN3,A0PS01,A1T2W5,Q1D936,Q3ISN0,B2A449,B9L6S4,C7Z193,Q5F9J5,B4RK98,A9M3P7,Q9JV25,Q9K012,A1KT71,A1D1M2,Q2GEH7,Q7S604,Q0AHF5,Q82V29,Q1QP77,Q2YBX2,Q3J808,A6Q5H2,Q3SNC6,Q5YNL6,A1SPV6,B2J8B7,Q8YMZ0,Q2G4V4,Q8EKX9,A6WY94,Q04EU8,A1R2A8,C1GUH5,C1FYF6,C0S3Z3,A6LIF5,A1AZM1,A7HV25,B2JIU0,B2SXR9,A0BD92,Q13X40,P57889,Q6D072,C6DFJ2,Q03ET4,Q3A828,Q3B6D0,B4SC75,A1ALC9,A5CY74,Q4FN13,B6GWE7,A9BHV4,Q0TXG3,B7FUM7,B4RDX2,Q6LM35,D0NVH9,A5DIP4,A3LYS9,Q6L2M3,Q4YU52,Q4X2S8,Q8IDF6,Q9U8D3,B3L781,A5K2F3,Q7RJF9,B2AWF0,A4SYD1,A1VNG5,B1XU85,Q12AC9,Q7MWW8,A3PBN1,A2C0W6,A8G3M2,A2C7N3,A9BEC8,A2BVG8,Q31C27,Q7VD77,B4F271,Q7V6A8,Q7V2H1,A2BPY8,Q46GR9,Q48NZ7,Q15ZE1,A6VD51,B7V201,Q02F80,Q9HUM6,B8HBV4,Q1I454,Q4KJ68,C3KDW8,A8F801,A4XPZ3,A5W9S5,Q3KIY4,B0KKZ0,Q88DD8,B1JAI0,Q87VJ9,O30549,Q4ZYX5,Q4FTX2,Q1QD25,A1SZK6,A5WGF9,Q9UYB3,Q8U3Z2,O58187,Q59726,B2VXY5,B2U9W0,Q8Y019,A9WV79,B3PY13,Q2K4X9,Q1MCS2,Q98F97,B5ZMS8,Q92MA5,Q7UHW3,B6ITA0,C0ZTG3,Q21W39,Q0S555,C1AWU5,Q2J0H0,Q07J18,Q6N1V9,Q20Z24,Q131X4,B3Q6W6,Q2RVD8,A3PL98,Q3J0Z3,A4WQW4,B9KKA7,B7JXN4,Q168S1,Q5LTU4,Q1GF65,B8I5L3,A1AWH8,Q21HA8,A4FQK6,B5F392,A9MFN5,Q57GL4,B5FRN3,B5R0P3,B5R9C3,B4TFB1,B4T2S2,Q5PL58,A9N4Z1,C0Q6D4,B5BKI5,Q2S1J1,B4TSF7,P65883,P65882,Q5D8V5,B6JUV1,C4QCD2,Q02787,A8G8V4,A1SA65,Q12RX5,Q07XS1,B0TUV4,A3QI59,Q8EAG5,A8H8L8,B8CIP5,B1KIH9,B2TY52,Q31TA7,Q328F6,Q0SXA5,Q83P33,Q3YUG6,C3MI14,A6UCR6,Q2NW58,Q026Q7,A9G5S0,D1ZRH0,Q1GVU1,A5VFF3,P52150,Q5HJX8,P65884,P99099,Q6GKS8,Q6GD73,Q8NYX6,Q5HK16,Q8CQK1,Q4LAK0,Q4A164,Q3JZ68,P65885,P65886,Q82ER6,Q9X8P6,C0MAE4,A8AZM9,B1VMC3,B4SS80,Q8DW14,Q9A1P8,Q04N48,P0DD54,Q5XE45,Q8P2U1,Q1JNS3,Q1JIX0,Q1J8S0,A2RCA2,B8ZJJ5,Q48VK8,P65887,P0DD55,B5XJH8,P65888,A4W440,C0MFY0,A3CQU5,Q5LXQ5,Q5M2A7,Q03IE5,B9DT31,Q30UH5,A6Q6M5,Q67J55,Q2LSI8,Q31KI0,A0LHR1,Q2JQX5,Q2JQ36,B1XIL5,Q5N1D4,A5GJD1,Q7U5D4,A5GSC3,Q0I8J6,Q3AWR7,Q3ALR7,Q0ATY3,P73290,B6QB86,B8M3A8,C5BRH0,B7IG20,Q9HIH2,Q4UAQ0,Q8DLG2,Q47KH7,C5A5E2,Q5JIE6,A6LJT4,Q9X0I1,B6YWD6,B0K8D7,Q4N3F4,B0K5I0,B9KYV8,C6A270,Q72GT4,Q5SLS1,Q97C15,B5YKK9,Q3SL57,B8GND3,C4L9M5,B3S0D3,Q10ZD0,Q3MBG1,Q83H67,Q83FF0,Q386E7,D0A6J7,C4JYB4,B1H0H8,Q4P7R2,A7TID0,C5CXH7,A1WMN5,A5CWQ5,A5F534,Q9KNX8,C3LRR4,P40607,Q8DCU4,Q7MH07,Q8D322,Q73I44,B3CL83,Q7M7V8,Q5GT12,C0R2U5,Q8PNB5,Q3BWF4,Q4URT6,B0RYD5,Q8PBR6,Q2P782,B2SNJ3,Q5H4F2,B2I7V8,Q9PG47,B0U498,Q87B33,Q6C482,B3LP64,C7GPD7,B5VQJ1,A6ZRM0,C8ZG13,P80210,A1JIS0,A7FMX4,Q1C105,B2K2K4,Q8ZIV7,A9QYM6,Q1CEG0,A4TRN4,Q66FB0,B1JMN3,C5DYR7,Q5NLU9">adenylosuccinate synthetase</z:uniprot> to abolish de novo AMP synthesis from <z:uniprot sup="inside" fb="123" ids="Q7Z569,Q99MP8,Q19420,Q54U72,O49071,Q6ZGL9,B9FJ61,O81062">IMP</z:uniprot> [13, 14, 30]. In vitro and in vivo, the growth inhibition of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient tumors by L-alanosine was partially ascribed to the induction of apoptosis, which was evidenced by increased <z:uniprot sup="inside" fb="0" ids="P81287,P17153,P70075,P08758,Q4R4H7,P48036,Q5R1W0,P14668">Annexin-V</z:uniprot> and TUNEL labeling in myxofibrosarcomas and reported to be mitochondria-dependent in mantle cell lymphomas [24]. </plain></SENT>
<SENT sid="289" pm="."><plain>In addition, we demonstrated that myxofibrosarcomas fundamentally depended on <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency regarding their susceptibility to L-alanosine, which effectively inhibited the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient cell lines and derived xenografts and was well-tolerated by the mice. </plain></SENT>
<SENT sid="290" pm="."><plain>Since several antimetabolites targeting purine synthesis are available and additional drugs are in development [32–34], the findings of this study suggest that <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient myxofibrosarcomas may benefit from the chemoselective targeting of the defects in methionine-adenine recycling and AMP synthesis. </plain></SENT>
</text></p><p><text><SENT sid="291" pm="."><plain>In summary, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> deficiency in myxofibrosarcomas, and particularly that caused by homozygous deletion, negatively affects prognosis. In vitro and in vivo, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> may act as a tumor suppressor, serving antiangiogenic, antiproliferative, and antimigratory or antiinvasive functions, and its deficiency represents a potential therapeutic target of myxofibrosarcomas. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="s4"><title><text><SENT sid="292" pm="."><plain>MATERIALS AND METHODS </plain></SENT>
</text></title><sec id="s4_1"><title><text><SENT sid="293" pm="."><plain>Analysis of aCGH </plain></SENT>
</text></title><p><text><SENT sid="294" pm="."><plain>Twelve fresh tumor specimens and 3 myxofibrosarcoma cell lines (OH931, NMFH-1, and NMFH-2) underwent oligonucleotide-based aCGH profiling (NimbleGen), as previously detailed [7, 15]. </plain></SENT>
<SENT sid="295" pm="."><plain>The raw data from the aCGH profiling were log2-transformed and output into Nexus software (BioDiscovery). </plain></SENT>
<SENT sid="296" pm="."><plain>To delineate the breakpoints in the genome-wide array probes, the gains and losses in the critical regions of the CNAs were defined as log2 ratios of ≥ +0.20 and ≤ −0.20, respectively. </plain></SENT>
<SENT sid="297" pm="."><plain>The amplification and homozygous deletion were defined as log2 ratios of ≥ +0.50 or ≤ −0.50, respectively. </plain></SENT>
<SENT sid="298" pm="."><plain>To unravel causal genes exhibiting copy number-driven deregulated expression, the common regions of alteration were filtered to identify consecutive makers, and their proportions were ^ 20% in the tumor and cell line samples analyzed. </plain></SENT>
</text></p></sec><sec id="s4_2"><title><text><SENT sid="299" pm="."><plain>Tumor materials </plain></SENT>
</text></title><p><text><SENT sid="300" pm="."><plain>An institutional review board (97-2190A3) approved the retrieval of myxofibrosarcomas resected with curative intent. </plain></SENT>
<SENT sid="301" pm="."><plain>Those undergoing neoadjuvant radiation, chemotherapy or aCGH profiling were excluded. </plain></SENT>
<SENT sid="302" pm="."><plain>Table 1 lists the 87 independent primary formalin-fixed myxofibrosarcomas successfully analyzed for <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene dosage, promoter methylation, and immunoexpression. </plain></SENT>
</text></p></sec><sec id="s4_3"><title><text><SENT sid="303" pm="."><plain>Immunohistochemistry </plain></SENT>
</text></title><p><text><SENT sid="304" pm="."><plain>Tissue microarray sections were antigen-retrieved, incubated with antibodies targeting <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> (1:100, Proteintech), Ki-67 (1:200, abcam), <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> (1:50, Epitomics), and CD31 (1:50, BD Pharmingen), and detected using the ChemMate EnVision kit. </plain></SENT>
<SENT sid="305" pm="."><plain>The cutoff value of &lt; 10% cytoplasmic reactivity to define aberrant <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> loss was previously described [22]. </plain></SENT>
<SENT sid="306" pm="."><plain>The scoring criteria of determining the levels of intratumoral microvessel density [18] and <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> expression by H-score method [19] were as previously reported. </plain></SENT>
<SENT sid="307" pm="."><plain>Whole sections of xenografted specimens were stained with <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> (1:50, Proteintech), <z:uniprot sup="inside" fb="0" ids="P42751">cyclin D1</z:uniprot> (1:100, Epitomics), <z:uniprot sup="inside" fb="1" ids="Q00268,Q00265,O01377,P24314,P17917,P12004,P17918,P17070,P61074,P31008,P04961,O16852,P22177,P53358,P18248">cyclin</z:uniprot> E (1:20, Abcam), Ki-67 (1:200, abcam), <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> (1:50, Epitomics), CD31 (1:50, BD Pharmingen), and TUNEL (Roche) for labeling apoptotic cells. </plain></SENT>
</text></p></sec><sec id="s4_4"><title><text><SENT sid="308" pm="."><plain><z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> dosage quantification </plain></SENT>
</text></title><p><text><SENT sid="309" pm="."><plain>As described in Supplementary Method-S1, real-time polymerase chain reaction (PCR) was performed on <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> exon 8 in duplicate for each case to detect the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene dosage. <z:uniprot sup="inside" fb="0" ids="P23727,P27986,Q5R685">PIK3R1</z:uniprot> (5q13.1) was the reference gene that exhibited no detectable CNAs in the aCGH. </plain></SENT>
<SENT sid="310" pm="."><plain>Standard curves were constructed using serial dilutions of human genomic DNA (Clontech). </plain></SENT>
<SENT sid="311" pm="."><plain>For each specimen, approximately 3000 tumor cells were microdissected using the Veritas LCM machine (Arcturus) to extract genomic DNA. </plain></SENT>
<SENT sid="312" pm="."><plain>The <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>/<z:uniprot sup="inside" fb="0" ids="P23727,P27986,Q5R685">PIK3R1</z:uniprot> ratio &lt; 0.2 was considered a homozygous deletion, assuming that the normal tissue contamination and intratumoral heterogeneity accounted for &lt; 20% of the experimental deviation. </plain></SENT>
<SENT sid="313" pm="."><plain>Regarding the 3 myxofibrosarcoma cell lines, homozygous deletion was determined when no <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene copy was detected but <z:uniprot sup="inside" fb="0" ids="P23727,P27986,Q5R685">PIK3R1</z:uniprot> was amplifiable, i.e. the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>/<z:uniprot sup="inside" fb="0" ids="P23727,P27986,Q5R685">PIK3R1</z:uniprot> ratio approximating zero. </plain></SENT>
</text></p></sec><sec id="s4_5"><title><text><SENT sid="314" pm="."><plain>Methylation-specific PCR </plain></SENT>
</text></title><p><text><SENT sid="315" pm="."><plain>Genomic DNA was extracted from formalin-fixed tissue, bisulfite-converted, and PCR-amplified with primers targeting methylated and unmethylated promoters of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene, as previously described [22]. </plain></SENT>
</text></p></sec><sec id="s4_6"><title><text><SENT sid="316" pm="."><plain>Cell culture, transfection, and RNA interference </plain></SENT>
</text></title><p><text><SENT sid="317" pm="."><plain>The culture conditions of the OH931, NMFH-1, and NMFH-2 myxofibrosarcoma cell lines, CCD966SK dermal fibroblasts, and human umbilical venous endothelial cells (HUVECs, H-UV001) were previously described [15] and were authenticated using short tandem-repeat fingerprinting in December, 2013. </plain></SENT>
</text></p><p><text><SENT sid="318" pm="."><plain>Regarding the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deleted OH931 and NMFH-2 cells, a full-length pMTAP-<z:uniprot sup="inside" fb="0" ids="P83638">DDK</z:uniprot>-<z:uniprot sup="inside" fb="92" ids="Q9W4S7,P01108,P09416">Myc</z:uniprot> expression plasmid and empty pCMV6 vector were purchased from Origene and validated using sequencing. </plain></SENT>
<SENT sid="319" pm="."><plain>In a 24-well plate, 105 cells from OH931 or NMFH-2 myxofibrosarcoma cell lines were seeded and incubated with lipofectamine 2000 (Invitrogene) for 4 h at 37°C to transfect various plasmids (1.5 μg), then cultured for a further 24 h at 37°C, and lysed with Passive Lysis Buffer (Promega). </plain></SENT>
<SENT sid="320" pm="."><plain>Cells stably expressing <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> or <z:uniprot sup="inside" fb="0" ids="P83638">DDK</z:uniprot>-<z:uniprot sup="inside" fb="92" ids="Q9W4S7,P01108,P09416">Myc</z:uniprot> tags alone were selected using neomycin. </plain></SENT>
<SENT sid="321" pm="."><plain>The transfected cells were analyzed for exogenous <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression using western blotting. </plain></SENT>
<SENT sid="322" pm="."><plain>To evaluate the <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot> promoter activity, an empty pGL vector and pG-<z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP-9</z:uniprot>-promoter were cotransfected with a pCMV6 control or a pMTAP-<z:uniprot sup="inside" fb="0" ids="P83638">DDK</z:uniprot>-<z:uniprot sup="inside" fb="92" ids="Q9W4S7,P01108,P09416">Myc</z:uniprot> vector into myxofibrosarcoma cells [35]. </plain></SENT>
<SENT sid="323" pm="."><plain>After 48 h, the cells underwent <z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">luciferase</z:uniprot> assays by using a dual <z:uniprot sup="inside" fb="2" ids="Q01158,P13129,Q26304,Q27757,P08659">luciferase</z:uniprot> assay kit (Promega) and normalized for the transfection efficiency of pRL vector. </plain></SENT>
</text></p><p><text><SENT sid="324" pm="."><plain>To silence the endogenous <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression in NMFH-1 cells, lentiviral vectors were obtained from the Taiwan National RNAi Core Facility. </plain></SENT>
<SENT sid="325" pm="."><plain>Viruses were produced by transfecting HEK293 cells with the control pLKO.1-shLacZ (TRCN0000072223: 5′-TGTTCGCATTAT CCGAACCAT-3′) and pLKO.1-shMTAP (TRCN0000005883: 5′-CCTGAATGATTTAGACAAC-3′ and TRCN0000005885: 5′-CCTTCTATGATGGAAGTCA-3′) using Lipofectamine 2000. </plain></SENT>
<SENT sid="326" pm="."><plain>For viral infection, 3 × 106 NMFH-1 cells were incubated with 8 mL of lentivirus in the presence of polybrene, followed by puromycin selection to produce stable clones of lentivirus-transduced cells. </plain></SENT>
</text></p></sec><sec id="s4_7"><title><text><SENT sid="327" pm="."><plain>Quantification of transcripts of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> and angiogenesis-associated genes </plain></SENT>
</text></title><p><text><SENT sid="328" pm="."><plain>As detailed in Method-S2, real-time reverse-transcription PCR (RT-PCR) was performed using the ABI StepOnePlus™ System to measure <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> mRNA abundance in all myxofibrosarcoma cell lines. </plain></SENT>
<SENT sid="329" pm="."><plain>To explore antiangiogenic mediators of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>, an RT-PCR expression array (PAHS-024, SABioscience) was profiled for NMFH-2 cells. </plain></SENT>
<SENT sid="330" pm="."><plain>Those genes differentially expressed between <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-reexpressing and empty conditions were identified based on P &lt; 0.001, &gt; 5-fold changes, and Ct values % 30 for both tested and housekeeping genes. </plain></SENT>
<SENT sid="331" pm="."><plain>These candidates were further screened in all myxofibrosarcoma cell lines using western blots to assay molecules exhibiting corresponding protein alterations under varying <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression or knockdown experiments. </plain></SENT>
</text></p></sec><sec id="s4_8"><title><text><SENT sid="332" pm="."><plain>Western blots </plain></SENT>
</text></title><p><text><SENT sid="333" pm="."><plain>To visualize protein expression alterations, Method-S3 details the western blots, sources of primary antibodies against <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>, G1- and G1/S transition-associated cell cycle regulators, and RT-PCR expression array-selected angiogenesis-associated mediators. </plain></SENT>
<SENT sid="334" pm="."><plain>The proteins consistently downregulated or upregulated by <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression in <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-deficient OH931 and NMFH-2 cells were reappraised in endogenously <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing NMFH-1 cells transduced with shMTAP or shLacZ. </plain></SENT>
</text></p></sec><sec id="s4_9"><title><text><SENT sid="335" pm="."><plain>Enzyme-linked immunosorbent assay (ELISA) </plain></SENT>
</text></title><p><text><SENT sid="336" pm="."><plain>After the aforementioned cross-validations were conducted, the identified molecule(s) exhibiting the same trend in changes in protein abundance, as modulated by the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> expression level, underwent ELISA to quantify their concentration in corresponding conditioned media, as detailed in Method-S4. </plain></SENT>
</text></p></sec><sec id="s4_10"><title><text><SENT sid="337" pm="."><plain>Pharmacological assessment </plain></SENT>
</text></title><p><text><SENT sid="338" pm="."><plain>Parent OH931, NMFH-2, and NMFH-1 cells, as well as the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>- or empty vector-transfected OH931 and NMFH-2 cells, were treated with a vehicle control using 0.9% phosphate-buffered saline (PBS) or L-alanosine (Santa Cruz Biotech) at indicated doses for 72 h. </plain></SENT>
</text></p></sec><sec id="s4_11"><title><text><SENT sid="339" pm="."><plain>Functional assays </plain></SENT>
</text></title><p><text><SENT sid="340" pm="."><plain>To elucidate the functional alterations associated with <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression, <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> knockdown, and L-alanosine treatment, various cancer phenotypes were evaluated using cell viability, bromodeoxyuridine (BrdU), electric cell-substrate impedance sensing (ECIS), cell cycle kinetics, soft-agar, HUVEC tube formation, and wound-healing, invasion, and apoptosis assays in Methods-S5-<z:uniprot sup="inside" fb="0" ids="P98175">S11</z:uniprot>. </plain></SENT>
</text></p></sec><sec id="s4_12"><title><text><SENT sid="341" pm="."><plain>Animal xenografts </plain></SENT>
</text></title><p><text><SENT sid="342" pm="."><plain>The animal use committee approved the protocol 103101401. </plain></SENT>
<SENT sid="343" pm="."><plain>To elucidate the in vivo function of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> reexpression, 4 × 106 NMFH-2 myxofibrosarcoma cells transfected with the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>-expressing plasmid or empty vector (n = 8 each) were inoculated into the flanks of 16 severe combined immunodeficient (SCID) mice (BioLasco) and allowed to grow until 30 d after cell implantation. </plain></SENT>
<SENT sid="344" pm="."><plain>To analyze the in vivo therapeutic effect of L-alanosine, 4 × 106 parent NMFH-2 cells were inoculated into 24 SCID mice, which were allowed to grow until 10 d postinjection (Day 0), and then randomized into 3 groups (n = 8 each) receiving 25 μM or 50 μM of L-alanosine, or PBS. </plain></SENT>
<SENT sid="345" pm="."><plain>The treatment was continued for 6 wk and the mice were euthanized 42 d posttreatment. </plain></SENT>
<SENT sid="346" pm="."><plain>The tumor volume was calculated using the formula: V=π/6 × length (mm) × width (mm)2. </plain></SENT>
</text></p></sec><sec id="s4_13"><title><text><SENT sid="347" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="348" pm="."><plain>The associations and comparisons among various parameters were evaluated using chi-square, Student t, or Mann-Whitney U test as appropriate to assess the <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene status and <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> immunoexpression. </plain></SENT>
<SENT sid="349" pm="."><plain>Follow-up data were available for 83 patients, and the median follow-up time was 30.6 mo. </plain></SENT>
<SENT sid="350" pm="."><plain>The endpoints were metastasis-free survival (<z:uniprot sup="inside" fb="7" ids="E5AE35">MFS</z:uniprot>) and disease-specific survival (DSS). </plain></SENT>
<SENT sid="351" pm="."><plain>Univariate survival analyses were compared using a log-rank test. </plain></SENT>
<SENT sid="352" pm="."><plain>A multivariate model was performed using a Cox regression, including parameters with univariate P &lt; 0.05. </plain></SENT>
<SENT sid="353" pm="."><plain>For cell line and xenograft samples, a Student's t-test was used to analyze the functional and pharmacological assays. </plain></SENT>
</text></p></sec></sec></SecTag><sec sec-type="supplementary-material" id="s5"><title><text><SENT sid="354" pm="."><plain>SUPPLEMENTARY METHODS, TABLES AND FIGURES </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="SD1"><media mimetype="application" mime-subtype="pdf" xlink:href="oncotarget-05-11428-s001.pdf" orientation="portrait" xlink:type="simple" id="d35e1735" position="anchor"/></supplementary-material></sec></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="355" pm="."><plain>The authors thank Dr. Bridge and Dr. Ogose for providing myxofibrosarcoma cells, and the Chang Gung genomic core laboratory (CMRPG880251) and tissue bank (CLRPG8B0033) for their assistance. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><SecTag type="ACK_FUND"><fn fn-type="supported-by"><p><text4fund><text><SENT sid="356" pm="."><plain>GRANT SUPPORTS </plain></SENT>
</text></text4fund></p><p><text4fund><text><SENT sid="357" pm="."><plain>This study was supported by the National Science Council (96-2320-B-182A-008-MY3 &amp; 102-2628-B-182A-002-MY3, H-Y Huang; 99-2320-B-384-001-MY2, C-F Li; NSC 98-2314-B-182A-100-MY3, F-M Fang), Ministry of Health and Welfare (MOHW103-TD-M-111-102001 to C-F Li and H-J Kung) and Chang Gung Memorial Hospital (CMRPG8C0981, XMRPG890061, H-Y Huang) of Taiwan. </plain></SENT>
</text></text4fund></p></fn></SecTag><SecTag type="COMP_INT"><fn fn-type="conflict"><p><text><SENT sid="358" pm="."><plain>Disclosure </plain></SENT>
</text></p><p><text><SENT sid="359" pm="."><plain>The authors declare no conflicts of interest. </plain></SENT>
</text></p></fn></SecTag></fn-group><SecTag type="REF"><ref-list><title>REFERENCES</title><ref id="R1"><text><SENT sid="360" pm="."><plain>1MentzelTCalonjeEWaddenCCamplejohnRSBehamASmithMAFletcherCDMyxofibrosarcoma. </plain></SENT>
<SENT sid="361" pm="."><plain>Clinicopathologic analysis of 75 cases with emphasis on the low-grade variantAm J Surg Pathol1996203914058604805 </plain></SENT>
</text></ref><ref id="R2"><text><SENT sid="362" pm="."><plain>2SanfilippoRMiceliRGrossoFFioreMPumaEPennacchioliEBarisellaMSangalliCMarianiLCasaliPGGronchiAMyxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institutionAnnals of surgical oncology201118720520878245 </plain></SENT>
</text></ref><ref id="R3"><text><SENT sid="363" pm="."><plain>3HuangHYLalPQinJBrennanMFAntonescuCRLow-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systemsHum Pathol2004356122115138937 </plain></SENT>
</text></ref><ref id="R4"><text><SENT sid="364" pm="."><plain>4WillemsSMDebiec-RychterMSzuhaiKHogendoornPCSciotRLocal recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression modelMod Pathol2006194071616415793 </plain></SENT>
</text></ref><ref id="R5"><text><SENT sid="365" pm="."><plain>5BarretinaJTaylorBSBanerjiSRamosAHLagos-QuintanaMDecarolisPLShahKSocciNDWeirBAHoAChiangDYRevaBSubtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyNat Genet2010427152120601955 </plain></SENT>
</text></ref><ref id="R6"><text><SENT sid="366" pm="."><plain>6LeeJCLiCFFangFMWangJWJengYMYuSCLinYTWuJMTsaiJWLiSHHuangHYPrognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysisMod Pathol20102313799220639860 </plain></SENT>
</text></ref><ref id="R7"><text><SENT sid="367" pm="."><plain>7LiCFWangJMKangHYHuangCKWangJWFangFMWangYHWuWRLiSHYuSCLeeJCLanJCharacterization of gene amplification-driven <z:uniprot sup="inside" fb="0" ids="Q13309,P42843">SKP2</z:uniprot> overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeuticsClin Cancer Res201218159861022322669 </plain></SENT>
</text></ref><ref id="R8"><text><SENT sid="368" pm="."><plain>8TsaiJWLiCFKaoYCWangJWFangFMWangYHWuWRWuLCHsingCHLiSHYuSCLanJRecurrent amplification at 7q21.2 Targets <z:uniprot sup="inside" fb="0" ids="Q00534">CDK6</z:uniprot> gene in primary myxofibrosarcomas and identifies <z:uniprot sup="inside" fb="0" ids="Q00534">CDK6</z:uniprot> overexpression as an independent adverse prognosticatorAnnals of surgical oncology20121927162522476749 </plain></SENT>
</text></ref><ref id="R9"><text><SENT sid="369" pm="."><plain>9ChristopherSADiegelmanPPorterCWKrugerWDMethylthioadenosine phosphorylase, a gene frequently codeleted with <z:uniprot sup="inside" fb="7" ids="Q9R0Z3,P0C044,P0C045,P0C794,P0C795,P26379">p16</z:uniprot>(cdkN2a/<z:uniprot sup="inside" fb="50" ids="Q7KQL3,Q94650,P51823,P34727,P0CM17,P0CM16,Q8N726,O77618,Q64364,Q8QZZ9,O48920">ARF</z:uniprot>), acts as a tumor suppressor in a breast cancer cell lineCancer Res20026266394412438261 </plain></SENT>
</text></ref><ref id="R10"><text><SENT sid="370" pm="."><plain>10KadariyaYTangBWangLAl-SaleemTHayakawaKSlifkerMJKrugerWDGermline Mutations in <z:uniprot sup="inside" fb="0" ids="Q9V813,Q9CQ65">Mtap</z:uniprot> Cooperate with <z:uniprot sup="inside" fb="92" ids="Q9W4S7,P01108,P09416">Myc</z:uniprot> to Accelerate Tumorigenesis in MicePLoS One20138e6763523840755 </plain></SENT>
</text></ref><ref id="R11"><text><SENT sid="371" pm="."><plain>11KadariyaYYinBTangBShintonSAQuinlivanEPHuaXKlein-SzantoAAl-SaleemTIBassingCHHardyRRKrugerWDMice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>) die prematurely of T-cell lymphomaCancer Res2009695961919567676 </plain></SENT>
</text></ref><ref id="R12"><text><SENT sid="372" pm="."><plain>12TangBLiYNKrugerWDDefects in methylthioadenosine phosphorylase are associated with but not responsible for methionine-dependent tumor cell growthCancer Res2000605543711034100 </plain></SENT>
</text></ref><ref id="R13"><text><SENT sid="373" pm="."><plain>13BatovaADiccianniMBNoboriTVuTYuJBridgemanLYuALFrequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapyBlood1996883083908874207 </plain></SENT>
</text></ref><ref id="R14"><text><SENT sid="374" pm="."><plain>14IlleiPBRuschVWZakowskiMFLadanyiMHomozygous deletion of <z:uniprot sup="inside" fb="0" ids="Q8N726,O77618,P42771,O77617">CDKN2A</z:uniprot> and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomasClin Cancer Res2003921081312796375 </plain></SENT>
</text></ref><ref id="R15"><text><SENT sid="375" pm="."><plain>15HuangHYWuWRWangYHWangJWFangFMTsaiJWLiSHHungHCYuSCLanJShiueYLHsingCHASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevanceClin Cancer Res20131928617223549872 </plain></SENT>
</text></ref><ref id="R16"><text><SENT sid="376" pm="."><plain>16CavuotoPFenechMFA review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extensionCancer Treat Rev2012387263622342103 </plain></SENT>
</text></ref><ref id="R17"><text><SENT sid="377" pm="."><plain>17PeggAERegulation of ornithine decarboxylaseJ Biol Chem2006281145293216459331 </plain></SENT>
</text></ref><ref id="R18"><text><SENT sid="378" pm="."><plain>18GaspariniGWeidnerNBevilacquaPMalutaSDalla PalmaPCaffoOBarbareschiMBoracchiPMarubiniEPozzaFTumor microvessel density, <z:uniprot sup="inside" fb="117" ids="Q9W678,O93379,P25035,P79820,O12946,Q9W679,O57538,Q92143">p53</z:uniprot> expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomaJ Clin Oncol199412454667509851 </plain></SENT>
</text></ref><ref id="R19"><text><SENT sid="379" pm="."><plain>19Budwit-NovotnyDAMcCartyKSCoxEBSoperJTMutchDGCreasmanWTFlowersJLMcCartyKSJrImmunohistochemical analyses of <z:uniprot sup="inside" fb="0" ids="Q9YHT3,Q91424,P49884,P06212,P57717,Q53AD2,Q9TV98,P03372,Q9YHZ7,P49886,Q9QZJ5,P57753,P19785,P16058,P50240,Q9YH33,P50241,O42132,Q29040,P06211,P50242,P49885,Q9PVZ9,Q91250,P81559">estrogen receptor</z:uniprot> in endometrial adenocarcinoma using a monoclonal antibodyCancer Res1986465419253756890 </plain></SENT>
</text></ref><ref id="R20"><text><SENT sid="380" pm="."><plain>20BehrmannIWallnerSKomyodWHeinrichPCSchuiererMBuettnerRBosserhoffAKCharacterization of methylthioadenosin phosphorylase (<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>) expression in malignant melanomaAm J Pathol20031636839012875987 </plain></SENT>
</text></ref><ref id="R21"><text><SENT sid="381" pm="."><plain>21HellerbrandCMuhlbauerMWallnerSSchuiererMBehrmannIBatailleFWeissTScholmerichJBosserhoffAKPromoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>) expression in hepatocellular carcinomaCarcinogenesis200627647216081515 </plain></SENT>
</text></ref><ref id="R22"><text><SENT sid="382" pm="."><plain>22HuangHYLiSHYuSCChouFFTzengCCHuTHUenYHTianYFWangYHFangFMHuangWWWeiYCHomozygous deletion of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> gene as a poor prognosticator in gastrointestinal stromal tumorsClin Cancer Res20091569637219887491 </plain></SENT>
</text></ref><ref id="R23"><text><SENT sid="383" pm="."><plain>23CrespoITaoHNietoABRebeloODominguesPVitalALPatino MdelCBarbosaMLopesMCOliveiraCROrfaoATaberneroMDAmplified and homozygously deleted genes in glioblastoma: impact on gene expression levelsPLoS One20127e4608823029397 </plain></SENT>
</text></ref><ref id="R24"><text><SENT sid="384" pm="."><plain>24MarceSBalagueOColomoLMartinezAHollerSVillamorNBoschFOttGRosenwaldALeoniLEstellerMFragaMFLack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapyClin Cancer Res20061237546116778103 </plain></SENT>
</text></ref><ref id="R25"><text><SENT sid="385" pm="."><plain>25OlopadeOIJenkinsRBRansomDTMalikKPomykalaHNoboriTCowanJMRowleyJDDiazMOMolecular analysis of deletions of the short arm of chromosome 9 in human gliomasCancer Res199252252391568221 </plain></SENT>
</text></ref><ref id="R26"><text><SENT sid="386" pm="."><plain>26SchmidMMalickiDNoboriTRosenbachMDCampbellKCarsonDACarreraCJHomozygous deletions of methylthioadenosine phosphorylase (<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>) are more frequent than <z:uniprot sup="inside" fb="0" ids="P42771">p16INK4A</z:uniprot> (<z:uniprot sup="inside" fb="0" ids="Q8N726,Q5E9Y0,P24941,P48963,P42771">CDKN2</z:uniprot>) homozygous deletions in primary non-small cell lung cancers (NSCLC)Oncogene1998172669759840931 </plain></SENT>
</text></ref><ref id="R27"><text><SENT sid="387" pm="."><plain>27HuangHYLiCFFangFMTsaiJWLiSHLeeYTWeiHMPrognostic implication of <z:uniprot sup="inside" fb="0" ids="P31976,P15311,P86232,P26040,Q8HZQ5,P31977">ezrin</z:uniprot> overexpression in myxofibrosarcomasAnnals of surgical oncology2010173212920585869 </plain></SENT>
</text></ref><ref id="R28"><text><SENT sid="388" pm="."><plain>28OverallCMKleifeldOTumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNat Rev Cancer200662273916498445 </plain></SENT>
</text></ref><ref id="R29"><text><SENT sid="389" pm="."><plain>29KirovskiGStevensAPCzechBDettmerKWeissTSWildPHartmannABosserhoffAKOefnerPJ-HellerbrandCDown-regulation of methylthioadenosine phosphorylase (<z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot>) induces progression of hepatocellular carcinoma via accumulation of 5′-deoxy-5′-methylthioadenosine (MTA)Am J Pathol201117811455221356366 </plain></SENT>
</text></ref><ref id="R30"><text><SENT sid="390" pm="."><plain>30AuvinenMCell transformation, invasion, and angiogenesis: a regulatory role for <z:uniprot sup="inside" fb="0" ids="P27117,P41931,P78599,Q8S3N2,P27118,P14019,P50134,P44317,P11926,P27116,P00860,P27119,P27121,P49725,Q92445,P09057,Q9UQW9,O22616,P07805,P08432">ornithine decarboxylase</z:uniprot> and polyamines?J Natl Cancer Inst19978953379106637 </plain></SENT>
</text></ref><ref id="R31"><text><SENT sid="391" pm="."><plain>31HolttaEPohjanpeltoPPolyamine dependence of Chinese hamster ovary cells in serum-free culture is due to deficient <z:uniprot sup="inside" fb="0" ids="P37818,Q10066,P14012,Q74ZW4,P53608,P39138,Q7M0Z3,P0A2Y1,P0A2X9,P0A2Y0,Q1E180,P40906,Q12611,Q6CLS8,P33280,O49046,P60086,P60087,P60088,Q6GER3,Q6G7E9,Q8NVE3,P00812">arginase</z:uniprot> activityBiochim Biophys Acta198272132177159597 </plain></SENT>
</text></ref><ref id="R32"><text><SENT sid="392" pm="."><plain>32LubinMLubinASelective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategyPLoS One20094e573519478948 </plain></SENT>
</text></ref><ref id="R33"><text><SENT sid="393" pm="."><plain>33BasuILockerJCasseraMBBelbinTJMerinoEFDongXHemeonIEvansGBGuhaCSchrammVLGrowth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5′-methylthioadenosine phosphorylaseJ Biol Chem201128649021121135097 </plain></SENT>
</text></ref><ref id="R34"><text><SENT sid="394" pm="."><plain>34TangBTestaJRKrugerWDIncreasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of <z:uniprot sup="inside" fb="0" ids="Q16MW6,Q9YAQ8,C0NRX4,E3XFR6,Q7Q9N9,Q4WMU1,Q3MHF7,Q89VT5,A8XGS6,Q09438,Q59ST1,C4YQD9,A0RVQ7,A9WAL0,F6X2V8,A8P7Y3,Q5KPU2,Q7ZV22,Q9V813,Q291H4,C8VP37,Q74E52,Q7NHW1,Q13126,A2BIU4,Q1INC3,Q72LZ4,Q8CXR2,F6RQL9,Q9CQ65,A0QR54,O06401,C7YLQ3,A7SN31,Q7RZA5,A9A3N5,Q0U796,Q7VDN6,Q9V2F1,Q8ZTB2,Q8U4Q8,O57865,Q2RXH9,Q3J5E8,Q97W94,Q09816,A7EAA1,P0DJF8,P0DJF9,Q9HL98,Q8DJE4,Q5JEQ6,A1RXU2,D5GFR0,Q4PH43,F6V515,Q6CES3,Q07938">MTAP</z:uniprot> in tumor cellsCancer Biol Ther20121310829022825330 </plain></SENT>
</text></ref><ref id="R35"><text><SENT sid="395" pm="."><plain>35LinLFChuangCHLiCFLiaoCCChengCPChengTLShenMRTsengJTChangWCLeeWHWangJMZBRK1 acts as a metastatic suppressor by directly regulating <z:uniprot sup="inside" fb="0" ids="P52176,O18733,P14780,P41245,P41246,P50282">MMP9</z:uniprot> in cervical cancerCancer Res20097019220119996286 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
